Serenity Bioworks Team
A team with a deep understanding of stress proteins, myeloid cells, and drug discovery.
Marsela Braunstein, PhD.
VP of Translation Research
Marsela earned her PhD in Immunology from the University of Toronto.
A decade of her career has been devoted to translating discoveries in cancer and autoimmunity. She has previously worked as a senior scientist and program manager at the Princess Margaret Hospital and the University Health Network in Toronto.
She is a leader for Serenity's work in immunology and helps guide our corporate strategy from a scientist's perspective.
Cody Shirriff, M.Sc
Chief Executive Officer
Cody did his M.Sc in Biology at the University of Waterloo. His research included the analysis of heat shock proteins and their roles in protecting kidney epithelial cells.
He has successfully raised venture financing, transacted and collaborated with pharmaceutical companies, and guided the early-stages for Serenity Bio.
His current role as CEO is to help build Serenity's team, assess new opportunities, and ensure Serenity's milestones are accomplished.
Justin Knapp, Ph.D
VP of Discovery Research
Justin earned his PhD in Biology from the University of Waterloo.
He has spent 10 years in discovery research and has previously worked at a contract research organization in southern Ontario.
Justin designs and executes Serenity's discovery stage studies and incorporates feedback from our advisors and consultants.
Spencer Berg, M.Sc
Chief Operating Officer
Spencer earned his M.Sc in Pharmacy from the University of Waterloo.
He has spent 6 years in discovery research and managing a cell biology laboratory.
Spencer's role involves managing our science team's laboratory and vivarium. He also works with our CROs and CMOs to ensure timelines and deliverables are met.